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Background: Gastrointestinal stromal tumors (GISTs) are nonepithelial, mesenchymal neoplasms that rarely occur
in children.
Case presentation: We present a unique case of a GIST that developed outside the gastrointestinal tract within the
mesoappendix of a 6-year old boy. Computed tomography (CT) revealed a slightly lobulated, homogeneous
soft-tissue mass, with marked contrast enhancement.
Conclusion: This case study provides new insight into the CT appearance of extragastrointestinal stromal tumors.
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Gastrointestinal stromal tumors (GISTs) are nonepithe-
lial, mesenchymal tumors that arise from the intestinal
cells of Cajal (ICC) or their stem cell precursors, and
constitute approximately 2% of all neoplasms of the
gastrointestinal tract [1]. These tumors very rarely occur
in children and young adults, who account for approxi-
mately 1.4% of all patients with GISTs [2]. The tumors
arise in the stomach in 40% to 70% of cases and in the
small intestine in 20% to 40% of cases, while less than
10% of tumors occur in the esophagus, colon, or rectum;
they usually present in adults over 40 years of age, with
a peak incidence in the sixth and seventh decades [3].
They may also originate from extragastrointestinal tract
sites, such as the omentum, mesentery, retroperitoneum,
pancreas, fallopian tubes, or uterus [4,5]. These are
termed extragastrointestinal stromal tumors (eGISTs),
and usually behave more aggressively. In this report, we
present the case of a GIST of the mesoappendix, and
focus on the CT findings and a review of the literature.* Correspondence: wenhuali@sjtu.edu.cn
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A developmentally normal 6-year-old boy was admitted
to our hospital for evaluation of lower abdominal pain
on the right side. Physical examination revealed a hard
and well-demarcated mass. Routine laboratory tests were
normal. Subsequently, an abdominal CT was performed
using a GE LightSpeed scanner (GE Medical Systems,
Milwaukee, WI, USA), with parameters of 120 kV and
180 mA. This revealed a mildly lobulated, well-defined
homogeneous soft-tissue mass, 5.0 × 5.7 × 6.7 cm in
size, in the right lower abdominal cavity, and there was
no evidence of pelvic lymphadenopathy (Figure 1). The
lesion had a density of 41 HU (Hounsfield units); it had
no hemorrhagic, necrotic, or cystic components. Follow-
ing infusion of a contrast agent, the tumor demonstrated
marked homogeneous enhancement, and a density of 81
HU. Laparotomy revealed a tan-colored mass arising
from the mesoappendix, without adhesions to the ap-
pendix or other organs and structures (Figure 2). Macro-
scopically, the mass was well-circumscribed, with an
incomplete capsule, and all margins were negative.
Microscopically, the tumor consisted of proliferating
spindle cells and epithelioid cells. Mitotic figures were
noted in 12 of 50 high-power fields. Immunohistochem-
ical staining revealed that the tumor was diffusely and
strongly positive for c-Kit (CD117) (Figure 3), myeloid
stem cell antigen (CD34), DOG1, and Ki-67, slightlyhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 CT of the pelvis (a): Axial pre-contrast image shows a
well-defined, slightly lobulated homogeneous soft-tissue mass
in the right lower abdominal cavity. (b): Reconstructed coronal
image shows the tumor with homogeneous enhancement without
necrotic or cystic components.
Figure 2 Operative image (a): The tan-colored tumor arises
from the mesoappendix. (b): The tumor was completely removed
without adhesions to the appendix or other organs or structures.
(c): Gross findings of the resected tumor. The tumor is tan-colored
with an incomplete capsule.
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actin (SMA), neuron-specific enolase (NSE), S-100, and
desmin. Based on these morphological and immunohis-
tochemical findings, the final pathological diagnosis
was that of a malignant gastrointestinal stromal tumor
of the mesoappendix. The patient was treated by
administration of Glevec as an adjuvant postoperative
chemotherapy and has been living disease-free for 9
months of follow-up.
Discussion
Primary eGISTs are distinctly uncommon, according to
previous reports [4,5]. An extensive literature review was
undertaken, using the key words ‘GIST,’ ‘Cajal cells,’
‘KIT,’ and ‘Imatinib.’ To the best of our knowledge, there
have been no previous reports of a GIST arising from
the mesoappendix. This case was positive for CD34 and
CD117, which supports the diagnosis, as this test distin-
guishes a GIST from mesenchymal tumors arising from
smooth muscle cells, such as leiomyomas, leiomyoblas-
tomas, and leiomyosarcomas. The origin of GISTs was
at first attributed to the ICC, but it is now recognized
that they arise from multipotential mesenchymal stemcells [6]. ICC or ICC-like cells have also been described
in various organs, excluding the gastrointestinal tract
[7]. In the case we present, the tumor may have origi-
nated from ICC or ICC-like cells and multipotential
mesenchymal stem cells in the mesoappendix.
It can be difficult to confirm a diagnosis of GIST,
and specific morphologic, immunohistochemical, and
Figure 3 High-power photomicrograph (hematoxylin-eosin, ×200) (a): The tumor is composed of spindle and epithelioid cells. (b):
CD117 immunostaining of the tumor; CD117 is diffusely and strongly positive in the tumor cells. (c): CD34 immunostaining of the tumor; D34 is
diffusely and strongly positive in the tumor cells.
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have a uniform appearance that falls into one of three
categories: spindle cell, epitheloid cell, and mixed cell.
On immunohistochemistry, 90% to 95% of GISTs are
diffusely and strongly positive for CD117 (c-Kit), but this
is no longer considered an absolute criterion. Not all
CD117-positive tumors are GISTs, as melanomas, syn-
ovial sarcomas, desmoid tumors, and schwannomas canalso be positive for this marker [1]. Some CD117 nega-
tive GISTs have an epithelioid morphology and arise in
the stomach or outside the gut. Therefore, CD34 has
been proposed as a more reproducible marker, and is
positive in 80% to 85% of cases. The spindle cell type is
more likely to stain with CD34 than the epithelioid type,
and the mixed spindle-epithelioid type is more likely to
stain with CD34 than the nonmixed type. Smooth
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positivity is present in up to 5% of these tumors, but is
relatively more common in small intestinal GISTs. In
general, GISTs tend to be negative for desmin, or weakly
positive in 1% to 2% of cases [1].
The spectrum of the clinical presentation of GISTs is
broad and depends on tumor location and size, with ap-
proximately 70% of patients developing such symptoms
as abdominal pain, gastrointestinal bleeding, and mass
effects. The remaining 20% to 30% present incidentally
during radiological imaging or surgery for some other
cause. The tumors occur with equal frequency in both
sexes, although some studies have shown a male prepon-
derance [1-3].
Since the classification of GIST as a distinct entity,
there has been an increased interest in defining the im-
aging characteristics. The tumors usually commence in
the bowel wall, but may extend to involve either the mu-
cosal or the serosal surfaces. Tumor size ranges from 1
cm to 35 cm, with a median of 5 cm. The tumor mar-
gins are well-defined in approximately two-thirds of
cases. They can be of any size, but large tumors, in par-
ticular, can have areas of hemorrhage and necrosis that
demonstrate a heterogeneous appearance on imaging.
The enhancement pattern can vary from homogeneous to
heterogeneous [8-10]. According to the World Health
Organization criteria [11], malignant potential is assessed
by tumor size, mitotic count, and the cell proliferative
index. Tumors smaller than 5 cm in diameter are usually
benign, those between 5 and 10 cm are of uncertain ma-
lignant potential, and those larger than 10 cm are usually
malignant. This case was a low-grade malignant GIST
according to these criteria, and to the criteria of a previ-
ous study [8-11].
Conclusions
In summary, we present the case of a GIST without
hemorrhagic, necrotic, or cystic components on CT.
Radiologists need to be aware of the imaging character-
istics of eGISTs. This rare case provides new insight into
the CT presentation of eGISTs.
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